180 related articles for article (PubMed ID: 32008331)
1. Radiation dose escalation for locally advanced unresectable intrahepatic and extrahepatic cholangiocarcinoma.
Avila S; Smani DA; Koay EJ
Chin Clin Oncol; 2020 Feb; 9(1):10. PubMed ID: 32008331
[TBL] [Abstract][Full Text] [Related]
2. External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence.
Sahai P; Kumar S
Br J Radiol; 2017 Aug; 90(1076):20170061. PubMed ID: 28466653
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.
Elganainy D; Holliday EB; Taniguchi CM; Smith GL; Shroff R; Javle M; Raghav K; Kaseb A; Aloia TA; Vauthey JN; Tzeng CD; Herman JM; Koong AC; Krishnan SX; Minsky BD; Crane CH; Das P; Koay EJ
Cancer Med; 2018 Oct; 7(10):4880-4892. PubMed ID: 30152073
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
[TBL] [Abstract][Full Text] [Related]
5. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.
Tao R; Krishnan S; Bhosale PR; Javle MM; Aloia TA; Shroff RT; Kaseb AO; Bishop AJ; Swanick CW; Koay EJ; Thames HD; Hong TS; Das P; Crane CH
J Clin Oncol; 2016 Jan; 34(3):219-26. PubMed ID: 26503201
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Brunner TB; Blanck O; Lewitzki V; Abbasi-Senger N; Momm F; Riesterer O; Duma MN; Wachter S; Baus W; Gerum S; Guckenberger M; Gkika E
Radiother Oncol; 2019 Mar; 132():42-47. PubMed ID: 30825968
[TBL] [Abstract][Full Text] [Related]
7. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.
Feng M; Smith DE; Normolle DP; Knol JA; Pan CC; Ben-Josef E; Lu Z; Feng MR; Chen J; Ensminger W; Lawrence TS
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1441-7. PubMed ID: 22440042
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial.
Laskar S; Sinha S; Chatterjee A; Khanna N; Manjali JJ; Puri A; Gulia A; Nayak P; Vora T; Chinnaswamy G; Prasad M; Bajpai J; Juvekar S; Desai S; Janu A; Rangarajan V; Purandare N; Shah S; Rekhi B; Jambhekar N; Muckaden MA; Kurkure P
Int J Radiat Oncol Biol Phys; 2022 Aug; 113(5):996-1002. PubMed ID: 35568246
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy in the treatment of cholangiocarcinoma.
Czito BG; Anscher MS; Willett CG
Oncology (Williston Park); 2006 Jul; 20(8):873-84; discussion 886-8, 893-5. PubMed ID: 16922259
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma.
Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T
Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683
[TBL] [Abstract][Full Text] [Related]
13. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.
Ghafoori AP; Nelson JW; Willett CG; Chino J; Tyler DS; Hurwitz HI; Uronis HE; Morse MA; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):654-9. PubMed ID: 20864265
[TBL] [Abstract][Full Text] [Related]
15. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
Bridgewater JA; Goodman KA; Kalyan A; Mulcahy MF
Am Soc Clin Oncol Educ Book; 2016; 35():e194-203. PubMed ID: 27249723
[TBL] [Abstract][Full Text] [Related]
16. Current biologics for treatment of biliary tract cancers.
Zhao DY; Lim KH
J Gastrointest Oncol; 2017 Jun; 8(3):430-440. PubMed ID: 28736630
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for liver tumors: ready for inclusion in guidelines?
Tanguturi SK; Wo JY; Zhu AX; Dawson LA; Hong TS
Oncologist; 2014 Aug; 19(8):868-79. PubMed ID: 25001265
[TBL] [Abstract][Full Text] [Related]
18. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
